Biotech | October 04, 2022
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Construction is now underway with the facility scheduled to be operational by 2025
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
Enriched with eight ayurvedic active ingredients like Ashwagandha, Shilajit, Shatavari, and Pippali, Be One works holistically to provide energy, build immunity and enable a healthy body and mind
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Subscribe To Our Newsletter & Stay Updated
